Feedback / Questions
ARB1002 - Arbele
https://www.prnewswire.com/news-releases/arbele-receives-fda-orphan-drug-designation-for-arb1002-an-anti-cdh17-antibodydrug-conjugate-for-the-treatment-of-pancreatic-cancer-302654913.html
Jan 7, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next